These data are a cornerstone in our research and build on our understanding of how MASH and cardiometabolic conditions like type 2 diabetes, obesity, dyslipidemia [abnormal fat levels in the blood], and high blood pressure are interrelated. Metabolic dysfunction-associated steatotic liver disease (MASLD), occurs when abnormal amounts of fat accumulate in the liver in the presence of cardiometabolic risk factors such as type 2 diabetes, obesity, high blood levels of cholesterol or other fats, or high blood pressure
If the patient cannot tolerate the 2.4mg dose, then decrease the dose to 1.7mg for 4 weeks
Simple, repeatable, and easy to shop for
You will have your weight and body measurements taken on the 3D Styku body composition scanner
Control de la glucemia La semaglutida est indicada para el tratamiento de segunda lnea de la diabetes de tipo 2 en pacientes que no pueden alcanzar niveles adecuados de hemoglobina glucosilada con metformina exclusivamente, o como primera lnea en pacientes que no toleran o no toman metformina
